BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8344041)

  • 21. [SPECT evaluation by acetazolamide test using 99m Tc-HMPAO in alternating hemiplegia of childhood].
    Miyamoto A
    No To Hattatsu; 1994 Jan; 26(1):80-2. PubMed ID: 8280454
    [No Abstract]   [Full Text] [Related]  

  • 22. Tc-99m HMPAO SPECT appearance of an atypical laminar heterotopia.
    Sieg KG; Gaffney GR; Preston DF; O'Donnell TL
    Clin Nucl Med; 1991 Dec; 16(12):949. PubMed ID: 1769182
    [No Abstract]   [Full Text] [Related]  

  • 23. Unexpected detection of an astrocytoma by poorly labeled Tc-99m HMPAO.
    Giordano A; Calcagni ML; DiFazio P; DeRossi G; Lauriola L
    Clin Nucl Med; 1996 Sep; 21(9):741-2. PubMed ID: 8879883
    [No Abstract]   [Full Text] [Related]  

  • 24. Tc-99m MDP uptake in cerebral infarction: comparison with Tc-99m DTPA brain scan and Tc-99m HMPAO brain SPECT.
    Peng NJ; Tsay DG; Chen CY; Liu RS; Yeh SH
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Oct; 56(4):283-7. PubMed ID: 8548673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cerebral perfusion reserve SPECT imaging before and during acetazolamide test using consecutive 99mTc-HMPAO SPECT].
    Terada H; Gomi T; Furukawa T; Murakami S; Sato S; Nagamoto M; Sekiguchi R; Kuwajima A; Hiramatsu Y; Sakai T
    Kaku Igaku; 1991 May; 28(5):509-15. PubMed ID: 1886285
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased brain retention of Tc-99m HMPAO following acetazolamide administration.
    Burt RW; Witt RM; Cikrit D; Carter J
    Clin Nucl Med; 1991 Aug; 16(8):568-71. PubMed ID: 1934809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward absolute quantitation of cerebral blood flow using technetium-99m-HMPAO and a single scan.
    Rattner Z; Smith EO; Woods S; Dey H; Hoffer PB
    J Nucl Med; 1991 Aug; 32(8):1506-7. PubMed ID: 1869969
    [No Abstract]   [Full Text] [Related]  

  • 28. Technetium-99m-HMPAO brain SPECT in patients with syndrome X.
    Weidmann B; Jansen WC; Bock A; Assheuer J; Tauchert MO
    Am J Cardiol; 1997 Apr; 79(7):959-61. PubMed ID: 9104912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HMPAO-SPECT and MRI in acute disseminated encephalomyelitis.
    Broich K; Horwich D; Alavi A
    J Nucl Med; 1991 Oct; 32(10):1897-900. PubMed ID: 1919728
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes of Tc-99m HMPAO brain distribution in herpes encephalitis.
    Le Scao Y; Turzo A; Guias M; Le Menn G; Garre M; Morin PP
    Clin Nucl Med; 1993 May; 18(5):452-3. PubMed ID: 8508589
    [No Abstract]   [Full Text] [Related]  

  • 31. Brain SPECT imaging in progressive aphasia.
    Lee H; Kramer JH
    Clin Nucl Med; 1992 Oct; 17(10):800-2. PubMed ID: 1424356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bilateral subdural hematomas diagnosed with technetium-99m-HMPAO brain SPECT.
    Coupland D; Lentle B
    J Nucl Med; 1991 Oct; 32(10):1915-7. PubMed ID: 1919732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 99mTc-HMPAO SPECT imaging in interventional neuroradiology: validation of balloon test occlusion.
    Moody EB; Dawson RC; Sandler MP
    AJNR Am J Neuroradiol; 1991; 12(6):1043-4. PubMed ID: 1763722
    [No Abstract]   [Full Text] [Related]  

  • 34. Prominent cisterna magna. Tc-99m HMPAO and MRI correlation.
    Spiegler EJ; Ratliff C
    Clin Nucl Med; 1991 Jun; 16(6):452. PubMed ID: 1868663
    [No Abstract]   [Full Text] [Related]  

  • 35. Discordant technetium-99m HMPAO and thallium-201 chloride distribution in brain tumors.
    Kamisaki Y; Seto H; Nagayoshi T; Kageyama M; Shimizu M; Wu YW; Watanabe N; Kakishita M
    Radiat Med; 1996; 14(3):155-8. PubMed ID: 8827811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral palsy: initial experience with Tc-99m HMPAO SPECT of the brain.
    Denays R; Tondeur M; Toppet V; Ham H; Piepsz A; Spehl M; Rubinstein M; Noel P
    Radiology; 1990 Apr; 175(1):111-6. PubMed ID: 2315468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD.
    Koyama M; Kawashima R; Ito H; Ono S; Sato K; Goto R; Kinomura S; Yoshioka S; Sato T; Fukuda H
    J Nucl Med; 1997 Apr; 38(4):587-92. PubMed ID: 9098207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unilateral hypotonic seizures successfully diagnosed by ictal SPECT with technetium-99m-HMPAO in a patient with a brain tumour.
    Date I; Kamitani M; Ohmoto T
    J Neurol Neurosurg Psychiatry; 1995 Apr; 58(4):509-10. PubMed ID: 7738572
    [No Abstract]   [Full Text] [Related]  

  • 39. SPECT evaluation of brain perfusion reserve by the acetazolamide test using Tc-99m HMPAO.
    Matsuda H; Higashi S; Kinuya K; Tsuji S; Nozaki J; Sumiya H; Hisada K; Yamashita J
    Clin Nucl Med; 1991 Aug; 16(8):572-9. PubMed ID: 1934810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What is the predictive value of increased technetium-99m-HMPAO uptake for brain survival/necrosis in the acute stage of ischemic stroke?
    Baron JC; Marchal G
    J Nucl Med; 1995 Dec; 36(12):2392-4. PubMed ID: 8523137
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.